Softhale Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $110M

  • Investors
  • 1

Softhale General Information

Description

Developer of inhalable therapeutic devices intended to improve respiratory treatments. The company's devices incorporate a proprietary set of technical configurations to spray a propellant-free liquid formulation in a highly efficient way to get the medication pass the natural curve of the throat providing time to naturally breathe in the medication, enabling physicians to get the medication deep into patient's lungs and relieve them from chronic respiratory conditions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • BioVille, Agoralaan
  • Building Abis
  • 3590 Diepenbeek
  • Belgium
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • BioVille, Agoralaan
  • Building Abis
  • 3590 Diepenbeek
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Softhale Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 31-Mar-2021 $110M Completed Generating Revenue
6. Early Stage VC 01-Jan-2020 Completed Generating Revenue
5. Early Stage VC (Series B) 01-Mar-2019 Completed Generating Revenue
4. Early Stage VC 23-Nov-2016 Completed Startup
3. Early Stage VC (Series A) 20-Jun-2016 Completed Startup
2. Grant 01-Jan-2016 $1.09M Completed Startup
1. Seed Round 01-Jan-2014 Completed Startup
To view Softhale’s complete valuation and funding history, request access »

Softhale Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference A
Preference A
Preference A 2,381 $22.78 $22.78 1x $22.78 1.1%
To view Softhale’s complete cap table history, request access »

Softhale Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Rhein Healthcare Venture Capital Minority
Vesalius Biocapital Partners Venture Capital Minority
To view Softhale’s complete investors history, request access »

Softhale FAQs

  • When was Softhale founded?

    Softhale was founded in 2012.

  • Where is Softhale headquartered?

    Softhale is headquartered in Diepenbeek, Belgium.

  • What industry is Softhale in?

    Softhale’s primary industry is Therapeutic Devices.

  • Is Softhale a private or public company?

    Softhale is a Private company.

  • What is the current valuation of Softhale?

    The current valuation of Softhale is .

  • What is Softhale’s current revenue?

    The current revenue for Softhale is .

  • How much funding has Softhale raised over time?

    Softhale has raised $3.44M.

  • Who are Softhale’s investors?

    New Rhein Healthcare and Vesalius Biocapital Partners have invested in Softhale.

  • When was Softhale acquired?

    Softhale was acquired on 31-Mar-2021.

  • Who acquired Softhale?

    Softhale was acquired by Sino Biopharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process